How to Raise HDL: What Moves the ‘Good’ Cholesterol, and Why Higher Is Not Always Better

A reader wrote in last month with a screenshot of her lab report and a question that is suddenly everywhere: her HDL was 48, a video had told her anything under 70 was “dangerous,” and she wanted to know whether a tablespoon of butter in her coffee would fix it. As of September 2026, searches for how to raise HDL have climbed again, driven by a wave of social posts promising to push the “good” cholesterol into the 80s with eggs, coconut oil and saturated fat, and by renewed interest in a new class of HDL-raising drugs working through late-stage trials.

The honest story is more interesting than the viral one. Lifestyle changes nudge HDL by a few points, and those same changes genuinely lower heart risk. Drugs that raise HDL dramatically have, so far, failed to prevent heart attacks. And the people with the very highest HDL readings do not turn out to be the healthiest. That paradox is the heart of this piece.

What changed recently: why everyone is asking how to raise HDL

HDL has been a moving target for fifteen years, and the recent spike in interest sits on top of a long paper trail. In 2011 the AIM-HIGH trial, which added extended-release niacin to statin treatment, was stopped early because raising HDL by about a quarter produced no fewer heart attacks or strokes. In 2014 the much larger HPS2-THRIVE trial, with more than 25,000 participants, reached the same conclusion and recorded more serious side effects in the niacin group. The NIH Office of Dietary Supplements still summarizes that record plainly: niacin raises HDL, but adding it to a statin has not improved cardiovascular outcomes.

The drug story then shifted to CETP inhibitors. CETP (cholesteryl ester transfer protein) is an enzyme that shuttles cholesterol out of HDL particles, so blocking it raises HDL steeply. Torcetrapib raised HDL by roughly 70 percent in 2007 and increased deaths. Evacetrapib more than doubled HDL in a trial reported in 2017 and prevented nothing. Anacetrapib, in the REVEAL trial the same year, did reduce events by about 9 percent, but the investigators attributed that gain to its LDL-lowering effect, not to the HDL rise.

Two threads explain the 2026 surge. One is a newer CETP inhibitor, obicetrapib, which reported large LDL and HDL changes in phase 3 lipid trials published in 2025; its cardiovascular outcomes trial is still running, so it remains an investigational medicine, not something available for self-use. The other is a social media trend treating HDL as a score to maximize with saturated fat. Mayo Clinic and Harvard Health both now carry the same cautious message: a higher HDL number from a pill or a diet hack has not been shown to translate into protection. That is the question this article unpacks.

What HDL cholesterol actually does in the body

Picture cholesterol as cargo and lipoproteins as the delivery trucks that carry it through the bloodstream. LDL (low-density lipoprotein) hauls cholesterol out to tissues, and when too much is dropped off in artery walls it builds the plaque behind heart attacks. HDL (high-density lipoprotein) runs the return route, collecting excess cholesterol from tissues, including from the immune cells lodged in artery plaque, and ferrying it back to the liver for disposal or recycling. That return journey is called reverse cholesterol transport.

HDL does other things that lab reports never show. The particle carries antioxidant enzymes, dampens inflammation in the vessel lining, and helps the artery wall produce nitric oxide, the molecule that lets vessels relax. Researchers now measure something called cholesterol efflux capacity, a laboratory test of how well a person’s HDL actually pulls cholesterol out of cells. In a 2014 study of nearly 3,000 adults, efflux capacity predicted future heart events better than the HDL cholesterol number did.

That distinction matters because a standard lipid panel does not count HDL particles or test their function. It measures how much cholesterol is riding inside them, reported in milligrams per deciliter (mg/dL) in the United States. Two people with identical HDL readings of 55 can have very different particle numbers and very different efflux capacity. Smoking, inflammation and poorly controlled diabetes can leave HDL present but sluggish, a state sometimes described as dysfunctional HDL.

The practical lesson is simple: HDL cholesterol is a useful marker of metabolic health, a bit like a dashboard light, rather than a quantity of protection you can top up. The habits that make the light turn green tend to improve the whole system, which is why they lower risk even when the HDL number moves only modestly.

What is a good HDL level, and what counts as low?

Most US laboratories flag HDL as low below 40 mg/dL for men and below 50 mg/dL for women, which corresponds roughly to 1.0 and 1.3 millimoles per liter (mmol/L) in countries that use those units. Readings of 60 mg/dL or above were historically labeled protective, and that number still appears on many reports. The 2018 cholesterol guideline from the American Heart Association and American College of Cardiology dropped HDL as a treatment target altogether, keeping it only as one input in the ten-year risk calculator.

Why the demotion? Observational data show a smooth gradient: across populations, people with HDL in the 30s have more heart disease than people in the 50s. But the relationship flattens out above about 60 mg/dL, and in several large cohorts it bends back upward past 80 to 90 mg/dL. A “good” HDL, in current thinking, is simply one that is not low. There is no evidence that moving from 60 to 75 buys anything.

Women run higher than men on average, by about 10 mg/dL, largely because of estrogen’s effect on liver lipoprotein production. HDL also drifts with age, falls temporarily during acute illness or after surgery, and can dip when triglycerides spike after a run of poor sleep or heavy drinking. A single reading taken during a bad month is not a verdict.

Interpretation depends on context more than on the number alone. An HDL of 42 in a lean, active nonsmoker with low triglycerides reads very differently from an HDL of 42 in someone with a large waist, fasting glucose at the edge of the diabetic range and triglycerides of 250. The second pattern, not the first, is the one clinicians act on, and the action is aimed at the metabolism behind the number.

Low HDL causes: what is the main cause of low HDL?

The single most common driver of low HDL in adults is insulin resistance, the state in which muscle, liver and fat cells respond poorly to insulin. It typically travels with excess abdominal fat, high triglycerides and a creeping fasting glucose, a cluster called metabolic syndrome. The mechanism is mechanical: when triglyceride-rich particles flood the bloodstream, CETP swaps triglyceride into HDL and cholesterol out of it. Triglyceride-laden HDL particles are then broken down quickly by the liver, so the HDL count falls. High triglycerides and low HDL are two faces of the same problem.

Genes come next. Variants affecting proteins such as ABCA1, apolipoprotein A-I and lipoprotein lipase can hold HDL in the 20s or 30s in people who do everything right. Rare conditions like Tangier disease produce HDL near zero. If several relatives share very low readings, inheritance is the likely explanation, and it is worth telling a clinician.

Behaviors and exposures fill in the rest. Smoking lowers HDL by roughly 4 to 6 mg/dL and impairs its function. Physical inactivity does the same quietly. Trans fats, now largely removed from the US food supply but still present in some imported and baked goods, lower HDL while raising LDL, the worst of both worlds. Diets very high in refined carbohydrate lower HDL too, which is why swapping saturated fat for white bread and sugar often leaves the ratio no better.

Several medicines reduce HDL, including some older beta blockers, anabolic steroids and certain progestin-containing hormone products. Poorly controlled type 2 diabetes, chronic kidney disease and liver disease also lower it. None of this means a prescribed medicine should be stopped; the trade-off belongs in a conversation with the prescriber, who can weigh an HDL dip against the reason the drug was started.

What the evidence actually says about raising HDL

Medical evidence comes in tiers. Randomized controlled trials, which assign people to an intervention or a comparison by chance, sit at the top. Observational studies, which follow people and record what happens, can show association but not cause. Mendelian randomization uses inherited gene variants as a natural experiment. Expert opinion anchors the bottom. Graded this way, the HDL story looks like this.

Intervention	Typical HDL change	Effect on heart events	Evidence strength
Aerobic exercise	+2 to +3 mg/dL on average	Lower risk, via many pathways	Randomized trials for HDL; observational for events
Weight loss (sustained)	About +0.35 mg/dL per kg lost	Lower risk with larger losses	Trials for lipids; observational for events
Stopping smoking	+4 to +6 mg/dL	Risk falls sharply within years	Strong observational and quasi-experimental
Replacing trans fat and refined carbs with unsaturated fat	+1 to +4 mg/dL	Lower risk in diet trials	Randomized feeding studies
Moderate alcohol	+3 to +5 mg/dL	No protection on genetic analysis	Mendelian randomization contradicts observational data
Niacin added to statin	+15 to +25 percent	No reduction	Two large randomized trials
CETP inhibitors	+70 to +130 percent	None attributable to HDL	Four large randomized trials

The table carries one sharp message. Everything in the top half raises HDL slightly and lowers risk substantially, because each also improves triglycerides, blood pressure, insulin sensitivity or LDL. Everything in the bottom half raises HDL dramatically and lowers risk not at all. A 2012 Mendelian randomization analysis in The Lancet, using variants that lift HDL without touching other lipids, found no reduction in heart attack risk, which is exactly what the drug trials later confirmed.

The fair conclusion is that HDL cholesterol behaves as a marker rather than a mechanism. Raising it is worthwhile only when the thing that raises it is itself protective.

Does exercise raise HDL? How much, and what kind works best

Exercise is the most consistently studied lifestyle lever for HDL, and the honest number is smaller than the headlines suggest. A meta-analysis of 25 randomized trials found that regular aerobic exercise raised HDL by an average of about 2.5 mg/dL. The gain was larger in people who started with higher total cholesterol or a higher body mass index, and it depended more on the length of each session than on how hard it was. Sessions of at least 20 minutes made a difference; every additional 10 minutes per session added roughly 1.4 mg/dL.

Volume seems to matter more than intensity. Walking, cycling, swimming and jogging all work, and brisk walkers who cover similar weekly distances see similar HDL changes to runners. The federal activity guideline of 150 minutes of moderate or 75 minutes of vigorous aerobic activity per week is the threshold at which most trials start to show movement. People who exceed it, such as endurance athletes, often run HDL in the 60s and 70s, but they also carry low triglycerides and high insulin sensitivity, which is the real signal.

Resistance training on its own has a weaker and less consistent HDL effect, though it improves glucose handling and preserves muscle, both of which feed back into triglycerides. Combining the two appears to be the most effective pattern, and it is what the American Heart Association recommends for general heart health anyway.

Timing expectations deserve a word. HDL responds over months, not days, and a reading taken within 24 hours of a hard workout can be temporarily skewed because triglycerides fall acutely. Anyone tracking the effect of a new routine should recheck after at least eight to twelve weeks of consistent activity, under the same fasting conditions as the first test, and look at the triglyceride and glucose columns alongside HDL. Those often move first.

Weight, waist and triglycerides: the metabolic lever most people overlook

If one number predicts where HDL will go, it is the triglyceride level. The two move in opposite directions so reliably that lipid specialists often describe them as a single “atherogenic dyslipidemia” pattern. Bring triglycerides down and HDL tends to rise without any direct effort, because fewer triglyceride-rich particles are available to strip cholesterol out of HDL through CETP exchange.

Weight loss is the most direct route to lower triglycerides. A classic pooled analysis of 70 studies estimated that each kilogram of sustained weight loss raises HDL by about 0.35 mg/dL, with a modest dip during the active losing phase followed by a rise once weight stabilizes. Lose 10 kilograms and keep it off, and the expected HDL gain is around 3 to 4 mg/dL, with triglycerides falling far more. Abdominal fat is the type that matters; waist circumference tracks HDL more closely than total weight does.

The composition of the diet during weight loss changes the lipid pattern. Low-fat, high-carbohydrate approaches tend to lower LDL more and HDL slightly, while lower-carbohydrate approaches tend to raise HDL and lower triglycerides but can push LDL up in some people. Trials comparing the two show both reduce weight and both improve overall risk markers; the HDL difference between them is real but small, and it should not be the reason to pick one over the other.

Sugar deserves specific mention. Added sugar, particularly in sweetened drinks, raises triglycerides within weeks even without weight gain, through increased fat production in the liver. Observational data link higher added-sugar intake to lower HDL, and short feeding trials support the mechanism. Cutting a daily sugary soda is one of the few dietary changes that plausibly moves HDL on its own, and it does so by fixing the triglyceride problem upstream.

Foods that raise HDL: what diet can and cannot do

No food contains HDL. The particles are made in the liver and intestine, so the question of “foods high in HDL” is a category mistake, like asking which foods are high in red blood cells. What diet can do is change the fats and carbohydrates the liver works with, and that shifts HDL by a few points.

The clearest evidence concerns fat type. Randomized feeding studies show that replacing refined carbohydrate with monounsaturated fat, the kind in olive oil, avocados and most nuts, raises HDL by roughly 2 to 4 mg/dL and lowers triglycerides. Replacing saturated fat with polyunsaturated fat, found in sunflower, soybean and corn oils, walnuts and fatty fish, lowers LDL substantially while leaving HDL roughly flat or slightly lower. Trans fats, listed on labels as partially hydrogenated oils, lower HDL and raise LDL; avoiding them is one of the few dietary moves that improves both.

Saturated fat itself raises HDL modestly, which is the kernel of truth inside the butter-in-coffee trend. The problem is that it raises LDL more, and LDL is the lipoprotein with randomized-trial proof behind lowering it. Trading a worse LDL for a cosmetically better HDL is not a winning exchange, and no outcome trial supports it.

Whole-food patterns do better than single ingredients. The Mediterranean-style diet, tested in a large Spanish randomized trial, raised HDL slightly and improved its function while cutting cardiovascular events by about 30 percent compared with a low-fat control. Fatty fish twice a week, a daily handful of nuts, legumes in place of some refined grains, and olive oil as the main added fat are the components with the most consistent support. Soluble fiber from oats, beans and fruit lowers LDL; its effect on HDL is neutral, which is fine, because the goal is a better overall profile, not a bigger HDL number.

Do eggs raise HDL? Sorting the viral claim from the trial data

Eggs are the mascot of the current trend, and the research is more nuanced than either camp admits. Several small randomized trials, typically lasting four to twelve weeks, found that eating one to three eggs a day raised HDL by a few mg/dL, particularly in people on lower-carbohydrate diets. The same trials usually showed a rise in LDL as well, so the ratio often changed little. Eggs also increase the size of both LDL and HDL particles, a shift some researchers consider favorable, though its clinical meaning is unproven.

The larger question is whether eggs affect heart disease, and here the observational evidence conflicts. A 2019 pooled analysis of US cohorts linked each additional half egg per day to a small rise in cardiovascular events; other large analyses, including several from Asian populations, found no association or a slight benefit at moderate intakes. Dietary cholesterol raises blood cholesterol less than saturated fat does, and the US Dietary Guidelines removed the old 300-milligram daily cholesterol cap in 2015 while still advising that intake stay as low as possible within a healthy eating pattern.

Mainstream guidance has settled into a pragmatic position. For most healthy adults, an egg a day fits within a heart-healthy diet. People with type 2 diabetes or high LDL are often advised to moderate intake, because the cohort data suggesting harm were strongest in those groups. What matters most is the company eggs keep; two eggs with vegetables and whole-grain toast is a different meal from two eggs with bacon, sausage and white toast.

So, do eggs raise HDL? Slightly, in some people, with a matching LDL rise that cancels much of the benefit. Eating eggs specifically to raise HDL is a weak strategy; eating them as part of an otherwise sensible pattern is reasonable for most people, and anyone with diabetes or elevated LDL should ask their clinician where the line sits for them.

Smoking, alcohol and sleep: three habits with outsized effects on HDL

Smoking is the lifestyle factor with the cleanest HDL signal. Pooled data from quit-smoking studies show HDL rising by roughly 4 mg/dL within weeks of stopping, a change comparable to a year of regular exercise. Cigarette smoke damages apolipoprotein A-I, the main protein scaffold of HDL, so smokers’ particles are both fewer and less functional. Quitting restores both, and the cardiovascular benefit arrives fast: excess heart attack risk roughly halves within a year of stopping. For smokers wondering how to raise HDL, this is the answer, and the gain in HDL is the least of its rewards.

Alcohol is the trap. Moderate drinking does raise HDL, by about 3 to 5 mg/dL, and for decades that fact underpinned the idea that a daily glass of wine protects the heart. Mendelian randomization studies have since dismantled the argument: people who carry gene variants that make them drink less have lower, not higher, cardiovascular risk, and the HDL rise from alcohol does not appear to protect anyone. The World Health Organization now states that no level of alcohol consumption is safe for health. The NHS and American Heart Association both advise against starting to drink for heart reasons. If you drink, keeping within national low-risk limits is sensible; using alcohol as an HDL tool is not.

Sleep is the quiet third factor. Short sleep, under six hours a night, and disrupted sleep from untreated obstructive sleep apnea are both associated with lower HDL and higher triglycerides in observational studies, likely through insulin resistance and stress hormones. Treating apnea improves the lipid pattern in some trials. Shift work shows a similar association. None of this evidence is strong enough to promise a specific HDL gain, but it fits the broader picture: HDL rises when the metabolism it reflects is working well, and sleep is part of that machinery.

What supplements raise HDL? Niacin, fish oil and the trial record

The supplement aisle sells HDL, and the evidence does not support the purchase. Niacin, also called vitamin B3, is the one compound that reliably raises HDL, by 15 to 35 percent at the pharmacological amounts used in trials, far above what any diet provides. The NIH Office of Dietary Supplements summarizes the outcome data: in AIM-HIGH and HPS2-THRIVE, adding niacin to statin therapy did not reduce heart attacks, strokes or deaths, and HPS2-THRIVE recorded more serious adverse events, including new diabetes, infections and bleeding. High-amount niacin is a prescription-level medicine with real risks, including liver injury and flushing, and is not something to self-manage.

Fish oil comes next in popularity. Over-the-counter omega-3 supplements lower triglycerides modestly and raise HDL by one or two percent at most. The large VITAL trial of a standard fish oil supplement found no reduction in major cardiovascular events in healthy adults. A prescription, purified EPA product did reduce events in people with high triglycerides already on statins in the 2018 REDUCE-IT trial, but it slightly lowered HDL rather than raising it, which again shows that the HDL number and the benefit travel separately. Decisions about prescription omega-3 belong to a clinician.

Red yeast rice, plant sterols, garlic, policosanol and green tea extracts have each been marketed for HDL. Plant sterols lower LDL by about 10 percent and leave HDL untouched. Red yeast rice contains a statin-like compound in unpredictable amounts and is not recommended as a substitute for a regulated medicine. For the rest, the trials are small, short and inconsistent; none shows an outcome benefit.

The question “what supplements raise HDL” has a defensible answer: niacin raises the number, nothing else does meaningfully, and no supplement has been shown to make that rise protective. Anyone already taking a supplement for cholesterol should mention it at their next appointment, because several interact with prescribed medicines.

Prescription medicines, CETP inhibitors and the search for an HDL drug

Every major cholesterol medicine touches HDL as a side effect of its main job. Statins raise it by roughly 5 to 10 percent while cutting LDL by 30 to 50 percent, and their trial record for preventing heart attacks and strokes is the strongest in cardiology. Ezetimibe, which blocks cholesterol absorption in the gut, and the PCSK9 inhibitors, injectable antibodies that help the liver clear LDL, each add a few percent to HDL incidentally. No clinician prescribes any of them for HDL; the HDL rise is a passenger.

Fibrates, such as fenofibrate and gemfibrozil, are the older medicines sometimes still used for the low-HDL, high-triglyceride pattern. They raise HDL by around 5 to 15 percent and lower triglycerides substantially. In the ACCORD lipid trial of people with type 2 diabetes, adding fenofibrate to a statin produced no overall benefit, with a possible gain only in the subgroup with the most abnormal pattern. A 2022 trial of pemafibrate in that exact subgroup also found no reduction in events. Guidelines now reserve fibrates mainly for very high triglycerides, where the concern is pancreatitis.

CETP inhibitors were designed specifically to raise HDL, and their history is the clearest test of the hypothesis. Four large trials, torcetrapib, dalcetrapib, evacetrapib and anacetrapib, produced HDL rises of 30 to 130 percent and either harm, nothing, or a small benefit traceable to LDL lowering. The field responded by redesigning the molecules around LDL. Obicetrapib, the current investigational candidate, is being studied primarily for its LDL reduction in people who cannot reach targets on existing therapy; its HDL rise is no longer the selling point. It is not approved, not available for purchase, and its outcomes data are pending.

The practical upshot for a patient is this: if a lipid panel shows low HDL, the medicine most likely to help is a statin, chosen for LDL and overall risk, and the decision about whether one is needed belongs to the prescribing clinician using the full risk picture.

Why higher is not always better: the U-shaped curve nobody expected

For decades HDL was taught as a dose-response good: more was better without limit. Large cohorts have dismantled that idea. In 2017 the Copenhagen General Population Study, following more than 100,000 adults, reported that men with HDL above about 97 mg/dL and women above about 135 mg/dL had higher all-cause mortality than those in the normal range, producing a U-shaped curve. A 2022 analysis in JAMA Cardiology of nearly 15,000 people with existing coronary disease found that HDL above 80 mg/dL was associated with a higher risk of death than HDL in the 40 to 60 range.

These are observational findings, so they prove association rather than cause, and several explanations are plausible. Heavy alcohol use raises HDL and shortens life. Some genetic variants that push HDL very high, including certain CETP and SR-B1 mutations, impair the liver’s ability to take cholesterol back from HDL, so the particles accumulate as cholesterol-stuffed dead ends rather than active couriers. Chronic inflammation can also produce HDL that is abundant but dysfunctional.

The point is not that a naturally high HDL is dangerous for most people. Many lean, active adults, especially women, run HDL in the 70s and 80s with excellent health. The point is that the number has stopped being a target. The 2018 US cholesterol guideline uses HDL only within the risk calculator, and no guideline sets an upper goal to aim for. Harvard Health captures the current view in its description of HDL as “the good, but complex, cholesterol.”

What should someone with an unexpectedly very high reading do? Not celebrate, and not panic. An HDL above about 90 mg/dL, especially alongside heavy drinking, abnormal liver tests or a strong family history, is worth a conversation with a clinician, who may look at particle function, alcohol intake and genetics rather than simply ticking the box marked “good.”

Common myths about raising HDL, corrected

The current viral wave rests on a handful of claims that sound plausible and fall apart under the trial data. Here is each one, with what the evidence actually shows.

• “Butter and coconut oil raise HDL, so they are heart-healthy.” Saturated fat does raise HDL by a few points, but it raises LDL by more, and LDL lowering is the change with randomized proof behind it. A 2020 Cochrane review of saturated-fat reduction trials found about a 17 percent cut in cardiovascular events. No trial shows that raising HDL with saturated fat protects anyone.
• “Any HDL under 70 is dangerous.” Laboratories flag HDL as low below 40 mg/dL in men and 50 in women. Risk flattens above about 60, and very high readings are not better. Seventy is not a medical threshold.
• “You can eat foods high in HDL.” HDL is made in the liver and intestine; no food contains it. Diet shifts production by a few points through fat type and sugar intake.
• “A glass of red wine a day raises HDL and protects the heart.” It raises HDL, and genetic studies show no protection. WHO states no level of alcohol is safe for health.
• “Niacin is a natural way to boost HDL.” At the amounts needed, niacin is a drug with documented liver and metabolic risks, and two large trials found no outcome benefit.
• “If my HDL is high, my LDL does not matter.” LDL remains the primary target in every major guideline. High HDL does not cancel a high LDL, and some people with very high HDL carry increased risk.

A pattern unites these myths: each treats HDL as a quantity of protection to accumulate. The evidence treats it as a readout of metabolic health. Fix the metabolism and the readout follows; chase the readout directly and nothing downstream improves.

How to raise HDL the honest way: a plan that puts the right numbers first

Having read the evidence, here is the opinion I hold with some confidence: the best way to raise HDL is to stop trying to raise HDL, and instead pursue the four changes that lift it as a byproduct while cutting risk through proven pathways.

Start with movement, because it is the most studied. Build toward 150 minutes a week of brisk aerobic activity in sessions of at least 20 to 30 minutes, and add two days of resistance work. Expect HDL to drift up 2 to 3 mg/dL over three months, and expect triglycerides to fall further and faster. Walking counts fully.

Second, aim at triglycerides through food. Replace sugary drinks with water or unsweetened alternatives, swap refined grains for whole ones and legumes, use olive oil as the main added fat, and eat fatty fish twice a week. This Mediterranean-style pattern has outcome-trial support, improves HDL function, and lowers LDL at the same time. Avoid partially hydrogenated oils entirely.

Third, if you smoke, quitting raises HDL more than any dietary tweak and halves excess heart risk within a year. Fourth, if your waist is above 40 inches (men) or 35 inches (women), modest sustained weight loss, even 5 to 7 percent of body weight, improves the whole lipid pattern and often moves fasting glucose with it.

What not to do is equally clear. Do not add saturated fat to raise a number. Do not start drinking. Do not buy niacin or fish oil expecting protection. And do not stop or change a prescribed medicine because a video blamed it for your HDL; take the question to the prescriber.

Finally, read the panel as a whole. LDL, non-HDL cholesterol and triglycerides carry more weight than HDL in every guideline, and the ten-year risk estimate, which folds in blood pressure, diabetes, age and smoking, is the number that drives treatment decisions. A clinician can run that calculation in a minute, and it tells you far more than HDL alone.

When to see a doctor about HDL and cholesterol

Cholesterol itself causes no symptoms, so the first reason to see a clinician is simply to have it measured. The CDC recommends that most healthy adults have a lipid panel every four to six years, with more frequent checks for people with heart disease, diabetes, kidney disease or a family history of high cholesterol, and that children have at least one screening test between ages 9 and 11 and again between 17 and 21. Anyone who has never been tested, or whose last test is more than five years old, has reason to book.

Certain lab patterns warrant a prompt, rather than routine, appointment. These include HDL below 30 mg/dL, HDL above about 90 mg/dL without an obvious explanation, triglycerides above 500 mg/dL, which raises the risk of pancreatitis, LDL above 190 mg/dL, which can signal familial hypercholesterolemia, and any lipid result that has changed sharply since the previous test. A family history of heart attack or stroke before age 55 in a male relative or 65 in a female relative also justifies earlier and more careful assessment.

Some signs need urgent care rather than a scheduled visit. Call emergency services for chest pain or pressure, especially with sweating, nausea or pain spreading to the arm, jaw or back; for sudden breathlessness; for sudden weakness or numbness on one side, facial drooping or slurred speech; and for fainting during exertion. Pain or cramping in the calves that comes on with walking and eases with rest can indicate peripheral artery disease and should be reported soon. Yellowish deposits around the eyelids or on tendons can indicate very high cholesterol and deserve evaluation.

If you take a cholesterol medicine and notice unexplained muscle pain, dark urine, yellowing of the skin or eyes, or severe flushing, contact the prescriber promptly rather than stopping on your own. Every decision about starting, adjusting or stopping a lipid medicine, including any question about niacin, fibrates or investigational drugs, belongs with the clinician who knows your full history and can weigh the whole risk picture.

Frequently asked questions

What is the main cause of low HDL?

Insulin resistance, usually travelling with excess abdominal fat and high triglycerides, is the most common cause of low HDL in adults. Triglyceride-rich particles swap their cargo into HDL, which is then cleared quickly by the liver. Genetics, smoking, physical inactivity, trans fats, diets heavy in refined carbohydrate, poorly controlled diabetes and certain medicines also lower HDL. A clinician can usually spot which pattern applies from the full lipid panel.

What supplements raise HDL?

Niacin is the only supplement that reliably raises HDL, by 15 to 35 percent at the amounts used in trials, but two large randomized trials found it did not prevent heart attacks or strokes when added to a statin and increased serious side effects. Fish oil raises HDL by one or two percent at most. No supplement has been shown to make an HDL rise protective, and any cholesterol supplement should be discussed with a clinician.

Do eggs raise HDL?

Slightly, in some people. Small trials of one to three eggs a day found HDL rose by a few mg/dL, but LDL usually rose too, so the overall ratio changed little. Observational studies on eggs and heart disease conflict, with the strongest signal of harm in people with type 2 diabetes. For most healthy adults an egg a day fits a heart-healthy diet; eating eggs specifically to raise HDL is a weak strategy.

What foods are high in HDL?

No food contains HDL. The particles are made in the liver and intestine, so the question is a category error. Foods can shift HDL production by a few points: olive oil, nuts, avocados and fatty fish nudge it up, trans fats and added sugar push it down. A Mediterranean-style pattern raises HDL slightly, improves its function and has randomized-trial evidence for fewer cardiovascular events, which is what actually matters.

What is a good HDL level?

An HDL of 40 mg/dL or higher in men and 50 mg/dL or higher in women is considered not low, and readings of 60 or more were historically labeled protective. Risk flattens above about 60, and very high readings above 80 to 90 are not better; several large cohorts link them to higher mortality. Current guidelines use HDL only within the overall risk calculation rather than as a target.

Does exercise raise HDL quickly?

No. HDL responds over months, not days. Trials typically show a rise of about 2 to 3 mg/dL after eight to twelve weeks of regular aerobic activity totaling at least 150 minutes a week, with longer sessions producing larger changes. Triglycerides often improve first. Recheck under the same fasting conditions as the original test, and look at the whole panel rather than HDL alone.

Can HDL be too high?

Possibly. Observational studies, including a 2017 Copenhagen cohort and a 2022 analysis in people with coronary disease, found higher mortality at HDL above roughly 80 to 97 mg/dL, producing a U-shaped curve. Explanations include heavy alcohol use and genetic variants that make HDL abundant but dysfunctional. A naturally high HDL in a healthy, active person is usually fine, but an unexpectedly very high reading is worth discussing with a clinician.

Does alcohol raise HDL, and is that good for the heart?

Moderate drinking raises HDL by about 3 to 5 mg/dL, but genetic studies show the rise does not protect against heart disease, and the World Health Organization states that no level of alcohol is safe for health. Major heart organizations advise against starting to drink for cardiovascular reasons. If you drink, staying within national low-risk limits is sensible; using alcohol as an HDL tool is not.

Does losing weight raise HDL?

Yes, modestly and mainly once weight stabilizes. Pooled data estimate about 0.35 mg/dL of HDL gain per kilogram of sustained loss, so a 10-kilogram loss raises HDL by roughly 3 to 4 mg/dL. Triglycerides fall much more, and fasting glucose and blood pressure often improve. Abdominal fat matters most; waist circumference tracks HDL more closely than total weight.

Should I take niacin to raise my HDL?

That decision belongs to your prescribing clinician, and the evidence makes it an uncommon choice. Niacin raises HDL substantially, but the AIM-HIGH and HPS2-THRIVE trials found no reduction in heart attacks or strokes when it was added to statin therapy, and HPS2-THRIVE recorded more serious adverse events including liver problems and new diabetes. Guidelines no longer recommend it for HDL raising.

References

• MedlinePlus: HDL: The "Good" Cholesterol
• NHS: How to lower your cholesterol

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.